Skip to main content

MoneyWorks4Me

Zydus Lifesciences informs about press release

27 Sep 2024 Evaluate
Zydus Lifesciences has informed that it enclosed a copy of press release dated September 27, 2024, titled ‘Zydus and CSIR-Central Drug Research Institute Lucknow to develop best-in-class drug for chronic kidney disease induced Osteoporosis’.

The above information is a part of company’s filings submitted to BSE. 
Peers
Company Name CMP
Sun Pharma. Inds. 1915.10
Dr. Reddys Labs. 1369.00
Cipla 1410.95
Lupin 1995.00
Zydus Lifesciences 1200.00
View more..